Search research articles
Contact Us
Filters
Showing results (341-350 of 389) with videos related to
Page
of 39
Sort By:
Allergy
|
September 5, 2014
A novel assay to diagnose hereditary angioedema utilizing inhibition of bradykinin-forming enzymes
K Joseph, S Bains, B G Tholanikunnel, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 3, 2004
Increased activity of antagonists of growth hormone-releasing hormone substituted at positions 8, 9, and 10
Jozsef L Varga, Andrew V Schally, Judit E Horvath, et al.
Neurogastroenterology and Motility
|
October 3, 2002
Influence of naloxone on gastric emptying of solid meals, myoelectrical gastric activity and blood hormone levels in young healthy volunteers
P U Reber, P Netzer, C Gaia, et al.
Seminars in Cancer Biology
|
July 11, 2000
H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cells
Z Radvány, Z Darvas, K Kerekes, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
September 1, 1995
Synthesis and bioactivity studies of 1-adamantanamine derivatives of peptides
S Horvat, L Varga-Defterdarović, J Horvat, et al.
Journal of Cognitive Neuroscience
|
January 10, 2025
Differentiation of Related Events in Hippocampus Supports Memory Reinstatement in Development
Nicole L Varga, Hannah E Roome, Robert J Molitor, et al.
Cancer Research
|
November 25, 2003
Antagonists of growth hormone-releasing hormone inhibit the proliferation of experimental non-small cell lung carcinoma
Zoltan Szereday, Andrew V Schally, Jozsef L Varga, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 18, 2005
Inhibition of human androgen-independent PC-3 and DU-145 prostate cancers by antagonists of bombesin and growth hormone releasing hormone is linked to PKC, MAPK and c-jun intracellular signalling
Anton Stangelberger, Andrew V Schally, Jozsef L Varga, et al.
The Prostate
|
August 30, 2008
Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138
Elmar Heinrich, Andrew V Schally, Stefan Buchholz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 1, 1995
Species differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and human
T Prueksaritanont, S K Balani, L M Dwyer, et al.
Page
of 39
Search research articles
Search
Showing results (341-350 of 389) with videos related to
Sort By:
Page
of 39
Allergy
|
September 5, 2014
A novel assay to diagnose hereditary angioedema utilizing inhibition of bradykinin-forming enzymes
K Joseph, S Bains, B G Tholanikunnel, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 3, 2004
Increased activity of antagonists of growth hormone-releasing hormone substituted at positions 8, 9, and 10
Jozsef L Varga, Andrew V Schally, Judit E Horvath, et al.
Neurogastroenterology and Motility
|
October 3, 2002
Influence of naloxone on gastric emptying of solid meals, myoelectrical gastric activity and blood hormone levels in young healthy volunteers
P U Reber, P Netzer, C Gaia, et al.
Seminars in Cancer Biology
|
July 11, 2000
H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cells
Z Radvány, Z Darvas, K Kerekes, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
September 1, 1995
Synthesis and bioactivity studies of 1-adamantanamine derivatives of peptides
S Horvat, L Varga-Defterdarović, J Horvat, et al.
Journal of Cognitive Neuroscience
|
January 10, 2025
Differentiation of Related Events in Hippocampus Supports Memory Reinstatement in Development
Nicole L Varga, Hannah E Roome, Robert J Molitor, et al.
Cancer Research
|
November 25, 2003
Antagonists of growth hormone-releasing hormone inhibit the proliferation of experimental non-small cell lung carcinoma
Zoltan Szereday, Andrew V Schally, Jozsef L Varga, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 18, 2005
Inhibition of human androgen-independent PC-3 and DU-145 prostate cancers by antagonists of bombesin and growth hormone releasing hormone is linked to PKC, MAPK and c-jun intracellular signalling
Anton Stangelberger, Andrew V Schally, Jozsef L Varga, et al.
The Prostate
|
August 30, 2008
Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138
Elmar Heinrich, Andrew V Schally, Stefan Buchholz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 1, 1995
Species differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and human
T Prueksaritanont, S K Balani, L M Dwyer, et al.
Page
of 39